QurAlis Corporation ("QurAlis"), a clinical-stage biotechnology company driving scientific breakthroughs into powerful precision medicines that have the potential to alter the trajectory of ...

Epilepsy diagnosis is an imperfect science. Approximately 30% of patients are misdiagnosed after their first visit.

An emerging type of artificial intelligence could improve the detection of seizures in epilepsy patients thanks to its ...

An emerging type of artificial intelligence could improve the detection of seizures in epilepsy patients thanks to its ...

A study at Johns Hopkins University found that a new tool could turn routine EEG tests into accurate predictors of epilepsy.

To tackle the challenges above, this paper proposes a novel approach—an epilepsy prediction framework that combines EEG-Inception Convolutional Neural Networks (EICNN) with Feature Pattern ...

22, 2025 — Doctors could soon reduce epilepsy misdiagnoses by up to 70% using a new tool that turns routine electroencephalogram, or EEG, tests that appear normal into highly accurate epilepsy ...

The following is a summary of “Comprehensive predictors of drug-resistant epilepsy in MELAS: clinical, EEG, imaging, and ...

Startup Cognixion, which has developed a noninvasive brain-computer interface, has begun a clinical trial for patients with ...

The wearable segment is experiencing remarkable growth, with a 15.1% increase in recent years. While advancements in wearable ...

Praxis' epilepsy pipeline takes center stage after Ulixacaltamide's Phase 3 futility. Key trials for vormatrigine and ...

"Our study confirms a substantial risk of epilepsy after neonatal seizures in neonatal survivors, with the highest risk ...